- Home
- CHMI vs IPA Comparison
CHMI vs IPA Comparison
Compare CHMI & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHMI
- IPA
- Stock Information
- Founded
- CHMI 2012
- IPA 1983
- Country
- CHMI United States
- IPA United States
- Employees
- CHMI N/A
- IPA N/A
- Industry
- CHMI Real Estate Investment Trusts
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- CHMI Real Estate
- IPA Health Care
- Exchange
- CHMI Nasdaq
- IPA Nasdaq
- Market Cap
- CHMI 89.2M
- IPA 98.9M
- IPO Year
- CHMI 2013
- IPA 2017
- Fundamental
- Price
- CHMI $2.71
- IPA $1.64
- Analyst Decision
- CHMI Hold
- IPA Strong Buy
- Analyst Count
- CHMI 1
- IPA 2
- Target Price
- CHMI N/A
- IPA $4.00
- AVG Volume (30 Days)
- CHMI 248.4K
- IPA 2.2M
- Earning Date
- CHMI 08-11-2025
- IPA 07-29-2025
- Dividend Yield
- CHMI 22.14%
- IPA N/A
- EPS Growth
- CHMI N/A
- IPA N/A
- EPS
- CHMI N/A
- IPA N/A
- Revenue
- CHMI $27,506,000.00
- IPA $17,744,713.00
- Revenue This Year
- CHMI N/A
- IPA $4.67
- Revenue Next Year
- CHMI $54.92
- IPA $14.15
- P/E Ratio
- CHMI N/A
- IPA N/A
- Revenue Growth
- CHMI 19.59
- IPA 0.01
- 52 Week Low
- CHMI $2.34
- IPA $0.27
- 52 Week High
- CHMI $3.83
- IPA $2.41
- Technical
- Relative Strength Index (RSI)
- CHMI 46.15
- IPA 51.14
- Support Level
- CHMI $2.64
- IPA $1.62
- Resistance Level
- CHMI $2.80
- IPA $2.41
- Average True Range (ATR)
- CHMI 0.08
- IPA 0.25
- MACD
- CHMI 0.01
- IPA -0.06
- Stochastic Oscillator
- CHMI 70.00
- IPA 13.48
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.